ATM protein is deficient in over 40% of lung adenocarcinomas.
Villaruz LC, Jones H, Dacic S, Abberbock S, Kurland BF, Stabile LP, Siegfried JM, Conrads TP, Smith NR, O'Connor MJ, Pierce AJ, Bakkenist CJ.
Villaruz LC, et al. Among authors: abberbock s.
Oncotarget. 2016 Sep 6;7(36):57714-57725. doi: 10.18632/oncotarget.9757.
Oncotarget. 2016.
PMID: 27259260
Free PMC article.